Total Payments
$684.91
2023 Payments
$25.52
Companies
4
Transactions
44
Medicare Patients
2,194
Medicare Billing
$304,919
Payment Breakdown by Category
Education$649.31 (94.8%)
Food & Beverage$35.60 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $649.31 | 41 | 94.8% |
| Food and Beverage | $35.60 | 3 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $609.74 | 41 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $39.51 | 1 | $0 (2020) |
| Celgene Corporation | $23.74 | 1 | $0 (2022) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $25.52 | 1 | PFIZER INC. ($25.52) |
| 2022 | $23.74 | 1 | Celgene Corporation ($23.74) |
| 2021 | $312.38 | 18 | PFIZER INC. ($300.46) |
| 2020 | $178.35 | 14 | PFIZER INC. ($138.84) |
| 2019 | $52.07 | 4 | PFIZER INC. ($52.07) |
| 2018 | $81.95 | 5 | PFIZER INC. ($81.95) |
| 2017 | $10.90 | 1 | PFIZER INC. ($10.90) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/26/2023 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $25.52 | General |
| Category: ONCOLOGY | ||||||
| 08/18/2022 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $23.74 | General |
| Category: Hematology | ||||||
| 12/20/2021 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $15.50 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2021 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $7.60 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2021 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $7.60 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2021 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $7.60 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2021 | PFIZER INC. | BOSULIF (Drug) | Education | In-kind items and services | $1.14 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/09/2021 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $15.50 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2021 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $15.50 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2021 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $12.00 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2021 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $12.00 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2021 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $15.50 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2021 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $15.50 | General |
| Category: ONCOLOGY | ||||||
| 09/21/2021 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $12.80 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2021 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $8.16 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2021 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $8.16 | General |
| Category: ONCOLOGY | ||||||
| 06/11/2021 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $124.40 | General |
| Category: ONCOLOGY | ||||||
| 06/11/2021 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $8.16 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 03/24/2021 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $13.34 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2020 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $13.34 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2020 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $8.16 | General |
| Category: ONCOLOGY | ||||||
| 08/19/2020 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $13.34 | General |
| Category: ONCOLOGY | ||||||
| 07/13/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $39.51 | General |
| Category: Oncology | ||||||
| 02/21/2020 | PFIZER INC. | BAVENCIO (Drug) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 420 | 748 | $220,960 | $62,884 |
| 2022 | 5 | 456 | 827 | $249,646 | $67,971 |
| 2021 | 5 | 566 | 1,071 | $300,399 | $94,580 |
| 2020 | 10 | 752 | 1,352 | $266,370 | $79,485 |
Total Patients
2,194
Total Services
3,998
Medicare Billing
$304,919
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 153 | 365 | $123,748 | $35,531 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 207 | 312 | $74,757 | $20,047 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $11,297 | $3,653 | 32.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $6,468 | $2,027 | 31.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 25 | $4,690 | $1,625 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 397 | $137,759 | $38,016 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 221 | 353 | $86,485 | $22,351 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $14,272 | $4,207 | 29.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $5,950 | $1,798 | 30.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 28 | $5,180 | $1,599 | 30.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 197 | 528 | $168,091 | $54,998 | 32.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 278 | 440 | $96,685 | $28,066 | 29.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 50 | 50 | $22,060 | $7,169 | 32.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 22 | 22 | $7,748 | $2,490 | 32.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 31 | $5,815 | $1,857 | 31.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 76 | 348 | $101,616 | $30,118 | 29.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 292 | 477 | $95,400 | $24,769 | 26.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 23 | 122 | $23,058 | $6,898 | 29.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 150 | 175 | $6,588 | $4,938 | 74.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 40 | 40 | $16,777 | $4,861 | 29.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 69 | 84 | $10,332 | $3,248 | 31.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 21 | 21 | $7,434 | $2,430 | 32.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 20 | 23 | $1,784 | $1,267 | 71.0% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 40 | 41 | $2,583 | $761.03 | 29.5% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 21 | 21 | $798.00 | $195.52 | 24.5% |
About Dr. C Choy, M.D
Dr. C Choy, M.D is a Hematology & Oncology healthcare provider based in Honolulu, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790799393.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. C Choy, M.D has received a total of $684.91 in payments from pharmaceutical and medical device companies, with $25.52 received in 2023. These payments were reported across 44 transactions from 4 companies. The most common payment nature is "Education" ($649.31).
As a Medicare-enrolled provider, Choy has provided services to 2,194 Medicare beneficiaries, totaling 3,998 services with total Medicare billing of $304,919. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Honolulu, HI
- Active Since 07/28/2006
- Last Updated 03/16/2012
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1790799393
Products in Payments
- INLYTA (Drug) $245.38
- LORBRENA (Drug) $161.86
- MYLOTARG (Biological) $60.15
- OPDIVO (Biological) $39.51
- XALKORI (Drug) $30.52
- BRAFTOVI (Drug) $26.08
- BAVENCIO (Drug) $23.79
- Pomalyst (Drug) $23.74
- BESPONSA (Biological) $21.80
- VIZIMPRO (Drug) $15.32
- IBRANCE (Drug) $12.80
- BESPONSA (Drug) $10.90
- BOSULIF (Drug) $1.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Honolulu
Dr. Tamie Kerns, D.o, D.O
Hematology & Oncology — Payments: $74,809
Hematology & Oncology $74,809
Dr. Ryon Nakasone, Md, MD
Hematology & Oncology — Payments: $25,691
Hematology & Oncology $25,691
Dr. Melvin Palalay, M.d, M.D
Hematology & Oncology — Payments: $21,120
Hematology & Oncology $21,120
Dr. Arnold Yee, M.d, M.D
Hematology & Oncology — Payments: $17,453
Hematology & Oncology $17,453
Dr. Kenneth Sumida, M.d, M.D
Hematology & Oncology — Payments: $17,239
Hematology & Oncology $17,239
Dr. Jared Acoba, M.d, M.D
Hematology & Oncology — Payments: $14,082
Hematology & Oncology $14,082